In vitro evaluation of sulbactam-durlobactam as a therapeutic alternative for multidrug-resistant <i>Acinetobacter baumannii</i> infections: insights from a tertiary care hospital

Abstract Objectives The Acinetobacter baumannii complex (ABC) is a hospital-acquired pathogen that exhibits high resistance, particularly to β-lactam antibiotics. The rise of β-lactamase enzymes, including carbapenemases, limits treatment options. New β-lactam/β-lactamase inhibitor (BL-BLI) combinations show promise, but information on their use in Indian hospitals is inadequate. The current study was designed to investigate the effectiveness of BL-BLI against ABC isolates, assess the impact of co-harboring various resistance genes on antibiotic effectiveness, and map the distribution pattern of these genes in clinical A. baumannii strains obtained from patients admitted at different wards and units of a tertiary care hospital using cluster analysis. Methods For the study, a total of 155 non-repetitive ABC isolates were isolated from specimens (n=9,753) collected from various critical care units and different inpatient departments of a tertiary care hospital. Antimicrobial susceptibility testing was performed on the isolates using Vitek-2 and Kirby-Bauer disc diffusion methods. Conventional PCR was performed to identify β-lactamase genes, including blaCTX-M, blaTEM, blaKPC, blaNDM, blaOXA-48 , and blaOXA-23 . The genetic relationships between ABC and the respective hospital wards from which they were isolated were studied using a dendrogram. Results Among BL-BLI combinations, sulbactam-durlobactam showed the highest effectiveness against blaOXA-23, blaKPC , and blaOXA-48 producing ABCs. However, it had limited activity against blaNDM -positive strains, whether alone or in combination. The PCR results reveal that the most widespread genes were blaOXA-23 (65.1 %) and blaNDM (60 %), respectively. Conclusions The high prevalence of carbapenemase genes in ABC isolates, which underscores the limited effectiveness of newer BL-BLI against NDM-positive strains.

Authors

Institutions

Publication Details

Journal
Journal of Laboratory Medicine
Published
2026-05-29
DOI
https://doi.org/10.1515/labmed-2026-0040
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In vitro evaluation of sulbactam-durlobactam as a therapeutic alternative for multidrug-resistant Acinetobacter baumannii infections: insights from a tertiary care hospital

Anroop B. Nair, Rohit Kumar, Mohammed Monirul Islam, Pottathil Shinu et al.
Journal of Laboratory Medicine
Antibiotic Resistance in Bacteria
article

In vitro evaluation of sulbactam-durlobactam as a therapeutic alternative for multidrug-resistant Acinetobacter baumannii infections: insights from a tertiary care hospital

Anroop B. Nair, Rohit Kumar, Mohammed Monirul Islam, Pottathil Shinu, H. D. Kumar, Md Aminur Rahman, Narinder Kaur
article en

Abstract

Abstract Objectives The Acinetobacter baumannii complex (ABC) is a hospital-acquired pathogen that exhibits high resistance, particularly to β-lactam antibiotics. The rise of β-lactamase enzymes, including carbapenemases, limits treatment options. New β-lactam/β-lactamase inhibitor (BL-BLI) combinations show promise, but information on their use in Indian hospitals is inadequate. The current study was designed to investigate the effectiveness of BL-BLI against ABC isolates, assess the impact of co-harboring various resistance genes on antibiotic effectiveness, and map the distribution pattern of these genes in clinical A. baumannii strains obtained from patients admitted at different wards and units of a tertiary care hospital using cluster analysis. Methods For the study, a total of 155 non-repetitive ABC isolates were isolated from specimens (n=9,753) collected from various critical care units and different inpatient departments of a tertiary care hospital. Antimicrobial susceptibility testing was performed on the isolates using Vitek-2 and Kirby-Bauer disc diffusion methods. Conventional PCR was performed to identify β-lactamase genes, including blaCTX-M, blaTEM, blaKPC, blaNDM, blaOXA-48 , and blaOXA-23 . The genetic relationships between ABC and the respective hospital wards from which they were isolated were studied using a dendrogram. Results Among BL-BLI combinations, sulbactam-durlobactam showed the highest effectiveness against blaOXA-23, blaKPC , and blaOXA-48 producing ABCs. However, it had limited activity against blaNDM -positive strains, whether alone or in combination. The PCR results reveal that the most widespread genes were blaOXA-23 (65.1 %) and blaNDM (60 %), respectively. Conclusions The high prevalence of carbapenemase genes in ABC isolates, which underscores the limited effectiveness of newer BL-BLI against NDM-positive strains.

Journal of Laboratory Medicine
Maharishi Markandeshwar University, Mullana (IN), King Faisal University (SA)
Good health and well-being
Openalex Percentile: Top 10%
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.